A 57-year-old woman undergoes treatment with chemotherapy for a recently diagnosed ovarian cancer. Her physician added mensa to her chemotherapeutic agents.

Which of these risks can be avoided by this new prescription?

A- Severe nausea and vomiting

B- Hair loss

C- Hemorrhagic cystitis

D- Iron deficiency anemia

E- Hepatic cyst


This patient is taking cyclophosphamide. Hemorrhagic cystitis is a common side effect to this chemotherapeutic agent. Mensa is used in combination with cyclophosphamide to prevent the development of hemorrhagic cystitis and transitional cell carcinoma.

The correct answer is C